Interactions of anti-COVID-19 drug candidates with hepatic transporters may cause liver toxicity and affect pharmacokinetics.
Sci Rep. 2021 Sep 8;11(1):17810. doi: 10.1038/s41598-021-97160-3.
Sci Rep. 2021.
PMID: 34497279
Free PMC article.